A citation-based method for searching scientific literature

Esther D A van Duin, Zuzana Kasanova, Dennis Hernaus, Jenny Ceccarini, Alexander Heinzel, Felix Mottaghy, Siamak Mohammadkhani-Shali, Oliver Winz, Michael Frank, Merrit C H Beck, Jan Booij, Inez Myin-Germeys, Thérèse van Amelsvoort. Eur Neuropsychopharmacol 2018
Times Cited: 4







List of co-cited articles
44 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome.
Maude Schneider, Martin Debbané, Anne S Bassett, Eva W C Chow, Wai Lun Alan Fung, Marianne van den Bree, Michael Owen, Kieran C Murphy, Maria Niarchou, Wendy R Kates,[...]. Am J Psychiatry 2014
408
75

The nature of dopamine dysfunction in schizophrenia and what this means for treatment.
Oliver D Howes, Joseph Kambeitz, Euitae Kim, Daniel Stahl, Mark Slifstein, Anissa Abi-Dargham, Shitij Kapur. Arch Gen Psychiatry 2012
546
75

Dopamine in high-risk populations: A comparison of subjects with 22q11.2 deletion syndrome and subjects at ultra high-risk for psychosis.
Claudia Vingerhoets, Oswald J N Bloemen, Erik Boot, Geor Bakker, Mariken B de Koning, Fabiana da Silva Alves, Jan Booij, Thérèse A M J van Amelsvoort. Psychiatry Res Neuroimaging 2018
4
75

Serotonergic, noradrenergic and dopaminergic markers are related to cognitive function in adults with 22q11 deletion syndrome.
Laurens J M Evers, Leopold M G Curfs, Jaap A Bakker, Erik Boot, Fabiana da Silva Alves, Nico Abeling, Jörgen Bierau, Marjan Drukker, Therese A M J van Amelsvoort. Int J Neuropsychopharmacol 2014
10
50

A neurogenetic model for the study of schizophrenia spectrum disorders: the International 22q11.2 Deletion Syndrome Brain Behavior Consortium.
R E Gur, A S Bassett, D M McDonald-McGinn, C E Bearden, E Chow, B S Emanuel, M Owen, A Swillen, M Van den Bree, J Vermeesch,[...]. Mol Psychiatry 2017
40
50

COMT Val(158) met genotype and striatal D(2/3) receptor binding in adults with 22q11 deletion syndrome.
Erik Boot, Jan Booij, Janneke R Zinkstok, Frank Baas, Ann Swillen, Michael J Owen, Declan G Murphy, Kieran C Murphy, Don H Linszen, Thérèse A Van Amelsvoort. Synapse 2011
16
50

Biological effects of COMT haplotypes and psychosis risk in 22q11.2 deletion syndrome.
Doron Gothelf, Amanda J Law, Amos Frisch, Jingshan Chen, Omer Zarchi, Elena Michaelovsky, Renee Ren-Patterson, Barbara K Lipska, Miri Carmel, Bhaskar Kolachana,[...]. Biol Psychiatry 2014
42
50

Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET.
Y Okubo, T Suhara, K Suzuki, K Kobayashi, O Inoue, O Terasaki, Y Someya, T Sassa, Y Sudo, E Matsushima,[...]. Nature 1997
520
50


Intact striatal dopaminergic modulation of reward learning and daily-life reward-oriented behavior in first-degree relatives of individuals with psychotic disorder.
Zuzana Kasanova, Jenny Ceccarini, Michael J Frank, Thérèse van Amelsvoort, Jan Booij, Esther van Duin, Henrietta Steinhart, Thomas Vaessen, Alexander Heinzel, Felix Mottaghy,[...]. Psychol Med 2018
9
50

Disrupted dopaminergic neurotransmission in 22q11 deletion syndrome.
Erik Boot, Jan Booij, Janneke Zinkstok, Nico Abeling, Lieuwe de Haan, Frank Baas, Don Linszen, Thérèse van Amelsvoort. Neuropsychopharmacology 2008
44
50

Distribution of D1- and D2-dopamine receptors, and dopamine and its metabolites in the human brain.
H Hall, G Sedvall, O Magnusson, J Kopp, C Halldin, L Farde. Neuropsychopharmacology 1994
307
50

Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: a positron emission tomographic functional magnetic resonance imaging study.
Mark Slifstein, Elsmarieke van de Giessen, Jared Van Snellenberg, Judy L Thompson, Rajesh Narendran, Roberto Gil, Elizabeth Hackett, Ragy Girgis, Najate Ojeil, Holly Moore,[...]. JAMA Psychiatry 2015
196
50

Striatal D₂ receptor binding in 22q11 deletion syndrome: an [¹²³I]IBZM SPECT study.
E Boot, J Booij, J R Zinkstok, L de Haan, D H Linszen, F Baas, T A van Amelsvoort. J Psychopharmacol 2010
18
50

Dopamine metabolism in adults with 22q11 deletion syndrome, with and without schizophrenia--relationship with COMT Val¹⁰⁸/¹⁵⁸Met polymorphism, gender and symptomatology.
Erik Boot, Jan Booij, Nico Abeling, Julia Meijer, Fabiana da Silva Alves, Janneke Zinkstok, Frank Baas, Don Linszen, Thérèse van Amelsvoort. J Psychopharmacol 2011
24
50

Prefrontal dopamine D1 receptors and working memory in schizophrenia.
Anissa Abi-Dargham, Osama Mawlawi, Ilise Lombardo, Roberto Gil, Diana Martinez, Yiyun Huang, Dah-Ren Hwang, John Keilp, Lisa Kochan, Ronald Van Heertum,[...]. J Neurosci 2002
503
50

Neuroimaging and clinical features in adults with a 22q11.2 deletion at risk of Parkinson's disease.
Nancy J Butcher, Connie Marras, Margarita Pondal, Pablo Rusjan, Erik Boot, Leigh Christopher, Gabriela M Repetto, Rosemarie Fritsch, Eva W C Chow, Mario Masellis,[...]. Brain 2017
26
50

Specific disruption of thalamic inputs to the auditory cortex in schizophrenia models.
Sungkun Chun, Joby J Westmoreland, Ildar T Bayazitov, Donnie Eddins, Amar K Pani, Richard J Smeyne, Jing Yu, Jay A Blundon, Stanislav S Zakharenko. Science 2014
73
50

Proton magnetic resonance spectroscopy in 22q11 deletion syndrome.
Fabiana da Silva Alves, Erik Boot, Nicole Schmitz, Aart Nederveen, Jacob Vorstman, Christina Lavini, Petra J Pouwels, Lieuwe de Haan, Don Linszen, Therese van Amelsvoort. PLoS One 2011
30
50

Dopaminergic function in cannabis users and its relationship to cannabis-induced psychotic symptoms.
Michael A P Bloomfield, Celia J A Morgan, Alice Egerton, Shitij Kapur, H Valerie Curran, Oliver D Howes. Biol Psychiatry 2014
125
50

The efficacy and heterogeneity of antipsychotic response in schizophrenia: A meta-analysis.
Robert A McCutcheon, Toby Pillinger, Yuya Mizuno, Adam Montgomery, Haridha Pandian, Luke Vano, Tiago Reis Marques, Oliver D Howes. Mol Psychiatry 2021
15
50

Cortical stress regulation is disrupted in schizophrenia but not in clinical high risk for psychosis.
Christin Schifani, Huai-Hsuan Tseng, Miran Kenk, Abanti Tagore, Michael Kiang, Alan A Wilson, Sylvain Houle, Pablo M Rusjan, Romina Mizrahi. Brain 2018
19
50

Is it Pre- or Postsynaptic? Imaging Striatal Dopamine Excess in Schizophrenia.
Mark Slifstein, Anissa Abi-Dargham. Biol Psychiatry 2018
12
50

Mesolimbic Dopamine Function Is Related to Salience Network Connectivity: An Integrative Positron Emission Tomography and Magnetic Resonance Study.
Robert A McCutcheon, Matthew M Nour, Tarik Dahoun, Sameer Jauhar, Fiona Pepper, Paul Expert, Mattia Veronese, Rick A Adams, Federico Turkheimer, Mitul A Mehta,[...]. Biol Psychiatry 2019
38
50

Elevated striatal dopamine function linked to prodromal signs of schizophrenia.
Oliver D Howes, Andrew J Montgomery, Marie-Claude Asselin, Robin M Murray, Isabel Valli, Paul Tabraham, Elvira Bramon-Bosch, Lucia Valmaggia, Louise Johns, Matthew Broome,[...]. Arch Gen Psychiatry 2009
484
50

Presynaptic striatal dopamine dysfunction in people at ultra-high risk for psychosis: findings in a second cohort.
Alice Egerton, Christopher A Chaddock, Toby T Winton-Brown, Michael A P Bloomfield, Sagnik Bhattacharyya, Paul Allen, Philip K McGuire, Oliver D Howes. Biol Psychiatry 2013
142
50

Nigral Stress-Induced Dopamine Release in Clinical High Risk and Antipsychotic-Naïve Schizophrenia.
Huai-Hsuan Tseng, Jeremy J Watts, Michael Kiang, Ivonne Suridjan, Alan A Wilson, Sylvain Houle, Pablo M Rusjan, Romina Mizrahi. Schizophr Bull 2018
18
50

Increased stress-induced dopamine release in psychosis.
Romina Mizrahi, Jean Addington, Pablo M Rusjan, Ivonne Suridjan, Alvina Ng, Isabelle Boileau, Jens C Pruessner, Gary Remington, Sylvain Houle, Alan A Wilson. Biol Psychiatry 2012
174
50


Striatal dopamine D1 and D2 receptor balance in twins at increased genetic risk for schizophrenia.
Jussi Hirvonen, Theo G M van Erp, Jukka Huttunen, Kjell Någren, Matti Huttunen, Sargo Aalto, Jouko Lönnqvist, Jaakko Kaprio, Tyrone D Cannon, Jarmo Hietala. Psychiatry Res 2006
23
50

Prefrontal NAA and Glx Levels in Different Stages of Psychotic Disorders: a 3T 1H-MRS Study.
Edith Liemburg, Anita Sibeijn-Kuiper, Leonie Bais, Gerdina Pijnenborg, Henderikus Knegtering, Jorien van der Velde, Esther Opmeer, Annerieke de Vos, Jozarni Dlabac-De Lange, Lex Wunderink,[...]. Sci Rep 2016
32
50

Striatal dopamine synthesis capacity in twins discordant for schizophrenia.
P Shotbolt, P R Stokes, S F Owens, T Toulopoulou, M M Picchioni, S K Bose, R M Murray, O D Howes. Psychol Med 2011
39
50

Striatal amphetamine-induced dopamine release in patients with schizotypal personality disorder studied with single photon emission computed tomography and [123I]iodobenzamide.
Anissa Abi-Dargham, Lawrence S Kegeles, Yolanda Zea-Ponce, Osama Mawlawi, Diana Martinez, Vivian Mitropoulou, Karen O'Flynn, Harold W Koenigsberg, Ronald Van Heertum, Thomas Cooper,[...]. Biol Psychiatry 2004
82
50

Proton MRS in twin pairs discordant for schizophrenia.
E S Lutkenhoff, T G van Erp, M A Thomas, S Therman, M Manninen, M O Huttunen, J Kaprio, J Lönnqvist, J O'Neill, T D Cannon. Mol Psychiatry 2010
98
50

Heterogeneity of Striatal Dopamine Function in Schizophrenia: Meta-analysis of Variance.
Stefan P Brugger, Ilinca Angelescu, Anissa Abi-Dargham, Romina Mizrahi, Vahid Shahrezaei, Oliver D Howes. Biol Psychiatry 2020
31
50

Defining the Locus of Dopaminergic Dysfunction in Schizophrenia: A Meta-analysis and Test of the Mesolimbic Hypothesis.
Robert McCutcheon, Katherine Beck, Sameer Jauhar, Oliver D Howes. Schizophr Bull 2018
73
50

Dopamine response to psychosocial stress in chronic cannabis users: a PET study with [11C]-+-PHNO.
Romina Mizrahi, Ivonne Suridjan, Miran Kenk, Tony P George, Alan Wilson, Sylvain Houle, Pablo Rusjan. Neuropsychopharmacology 2013
31
50

Loss of asymmetry in D2 receptors of putamen in unaffected family members at increased genetic risk for schizophrenia.
K J Lee, J S Lee, S J Kim, C U Correll, H Wee, S Y Yoo, J M Jeong, D S Lee, S I Lee, J S Kwon. Acta Psychiatr Scand 2008
15
50

Glutamatergic and dopaminergic function and the relationship to outcome in people at clinical high risk of psychosis: a multi-modal PET-magnetic resonance brain imaging study.
Oliver D Howes, Ilaria Bonoldi, Robert A McCutcheon, Matilda Azis, Mathilde Antoniades, Matthijs Bossong, Gemma Modinos, Jesus Perez, James M Stone, Barbara Santangelo,[...]. Neuropsychopharmacology 2020
11
50

Striatal dopamine synthesis in first-degree relatives of patients with schizophrenia.
Jukka Huttunen, Markus Heinimaa, Tanja Svirskis, Mikko Nyman, Jaana Kajander, Sarita Forsback, Olof Solin, Tuula Ilonen, Jyrki Korkeila, Terja Ristkari,[...]. Biol Psychiatry 2008
82
50

Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging study.
Oliver D Howes, Subrata K Bose, Federico Turkheimer, Isabel Valli, Alice Egerton, Lucia R Valmaggia, Robin M Murray, Philip McGuire. Am J Psychiatry 2011
226
50

GABA levels and TSPO expression in people at clinical high risk for psychosis and healthy volunteers: a PET-MRS study.
Tania Da Silva, Sina Hafizi, Pablo M Rusjan, Sylvain Houle, Alan A Wilson, Ivana Prce, Napapon Sailasuta, Romina Mizrahi. J Psychiatry Neurosci 2019
17
50


Increased left striatal dopamine transmission in unaffected siblings of schizophrenia patients in response to acute metabolic stress.
Jerome Brunelin, Thierry d'Amato, Jim Van Os, Nicolas Costes, Marie-Françoise Suaud Chagny, Mohamed Saoud. Psychiatry Res 2010
31
50


Attenuated positive symptoms of psychosis in adolescents with chromosome 22q11.2 deletion syndrome.
Joel Stoddard, Tara Niendam, Robert Hendren, Cameron Carter, Tony J Simon. Schizophr Res 2010
57
25

Stress-induced dopamine release in human medial prefrontal cortex--18F-fallypride/PET study in healthy volunteers.
Atsuko Nagano-Saito, Alain Dagher, Linda Booij, Paul Gravel, Krzysztof Welfeld, Kevin F Casey, Marco Leyton, Chawki Benkelfat. Synapse 2013
50
25

Functional gene-expression analysis shows involvement of schizophrenia-relevant pathways in patients with 22q11 deletion syndrome.
Nico J M van Beveren, Lianne C Krab, Sigrid Swagemakers, Gabriëlle H S Buitendijk, Erik Boot, Peter van der Spek, Ype Elgersma, Therese A M J van Amelsvoort. PLoS One 2012
25
25


Catechol-o-methyltransferase enzyme activity and protein expression in human prefrontal cortex across the postnatal lifespan.
E M Tunbridge, C S Weickert, J E Kleinman, M M Herman, J Chen, B S Kolachana, P J Harrison, D R Weinberger. Cereb Cortex 2007
106
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.